| Ident. | Authors (with country if any) | Title |
|---|
| 000056 (2020) |
Paolo Verdecchia ; Gianpaolo Reboldi ; Claudio Cavallini ; Giovanni Mazzotta ; Fabio Angeli | [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus]. |
| 000185 (2020) |
Rameez Jabeer Khan [Inde] ; Rajat Kumar Jha [Inde] ; Gizachew Muluneh Amera [Inde] ; Monika Jain [Inde] ; Ekampreet Singh [Inde] ; Amita Pathak [Inde] ; Rashmi Prabha Singh [Inde] ; Jayaraman Muthukumaran [Inde] ; Amit Kumar Singh [Inde] | Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase. |
| 000189 (2020) |
Yixian Liao [République populaire de Chine] ; Yilu Ye [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Yilian Zhuang [République populaire de Chine] ; Liye Chen [République populaire de Chine] ; Jianxin Chen [République populaire de Chine] ; Zining Cui [République populaire de Chine] ; Lijian Huo [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Synthesis and SARs of dopamine derivatives as potential inhibitors of influenza virus PAN endonuclease. |
| 000331 (2020) |
Thanigaimalai Pillaiyar [Allemagne] ; Sangeetha Meenakshisundaram [Inde] ; Manoj Manickam [Inde] | Recent discovery and development of inhibitors targeting coronaviruses |
| 000463 (2020) |
Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000467 (2020) |
I. Aanouz [Maroc] ; A. Belhassan [Maroc] ; K. El Khatabi [Maroc] ; T. Lakhlifi [Maroc] ; M. El Idrissi [Maroc] ; M. Bouachrine [Maroc] | Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations. |
| 000540 (2020) |
Thorsten Kessler [Allemagne] ; Heribert Schunkert [Allemagne] | Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection |
| 000575 (2020) |
Salman Ali Khan [Pakistan] ; Komal Zia [Pakistan] ; Sajda Ashraf [Pakistan] ; Reaz Uddin [Pakistan] ; Zaheer Ul-Haq [Pakistan] | Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. |
| 000720 (2020) |
Han Ju [République populaire de Chine] ; Siyu Xiu [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Min Shang [République populaire de Chine] ; Ruifang Jia [République populaire de Chine] ; Bing Huang [République populaire de Chine] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity. |
| 000783 (2020) |
Junyi Guo ; Zheng Huang ; Li Lin ; Jiagao Lv | Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
| 000991 (2020) |
Abdo A. Elfiky | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 |
| 000A86 (2019) |
Kaijun Jin [République populaire de Chine] ; Yali Sang [République populaire de Chine] ; Sheng Han [République populaire de Chine] ; Erik De Clercq [Belgique] ; Christophe Pannecouque [Belgique] ; Ge Meng [République populaire de Chine] ; Fener Chen [République populaire de Chine] | Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains. |
| 000A87 (2019) |
Yixian Liao [République populaire de Chine] ; Lizhu Chen [République populaire de Chine] ; Sumei Li [République populaire de Chine] ; Zi-Ning Cui [République populaire de Chine] ; Zhiwei Lei [République populaire de Chine] ; Hui Li [République populaire de Chine] ; Shuwen Liu [République populaire de Chine] ; Gaopeng Song [République populaire de Chine] | Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index. |
| 000A96 (2019) |
Erofili Giannakopoulou [Grèce] ; Vasiliki Pardali [Grèce] ; Efseveia Frakolaki [Grèce] ; Vasileios Siozos [Grèce] ; Vassilios Myrianthopoulos [Grèce] ; Emmanuel Mikros [Grèce] ; Martin C. Taylor [Royaume-Uni] ; John M. Kelly [Royaume-Uni] ; Niki Vassilaki [Grèce] ; Grigoris Zoidis [Grèce] | Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species. |
| 000B59 (2019) |
Ji Yu [République populaire de Chine] ; Xiaowei Guo [République populaire de Chine] ; Samuel Desta [République populaire de Chine] ; Shuo Zhang [République populaire de Chine] ; Jian Zhang [République populaire de Chine] ; Xiao Ding [République populaire de Chine] ; Xiaohong Liang [République populaire de Chine] ; Haiyong Jia [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] | Design, Synthesis and Evaluation of Novel Heteroaryldihydropyrimidines Derivatives as Non-nucleoside Hepatitis B Virus Inhibitors by Exploring the Solvent-exposed Region. |
| 000C01 (2018) |
Dominik Dolles [Allemagne] ; Matthias Hoffmann [Allemagne] ; Sandra Gunesch [Allemagne] ; Oliviero Marinelli [Italie] ; Jan Möller [Allemagne] ; Giorgio Santoni [Italie] ; Arnaud Chatonnet [France] ; Martin J. Lohse [Allemagne] ; Hans-Joachim Wittmann [Allemagne] ; Andrea Strasser [Allemagne] ; Massimo Nabissi [Italie] ; Tangui Maurice [France] ; Michael Decker [Allemagne] | Structure–activity relationships and computational investigations into the development of potent and balanced dual-acting butyrylcholinesterase inhibitors and human cannabinoid receptor 2 ligands with pro-cognitive in vivo profiles |
| 000C54 (2018) |
Brian L. Venables [États-Unis] ; Ny Sin [États-Unis] ; Alan Xiangdong Wang [États-Unis] ; Li-Qiang Sun [États-Unis] ; Yong Tu [États-Unis] ; Dennis Hernandez [États-Unis] ; Amy Sheaffer [États-Unis] ; Min Lee [États-Unis] ; Cindy Dunaj [États-Unis] ; Guangzhi Zhai [États-Unis] ; Diana Barry [États-Unis] ; Jacques Friborg [États-Unis] ; Fei Yu [États-Unis] ; Jay Knipe [États-Unis] ; Jason Sandquist [États-Unis] ; Paul Falk [États-Unis] ; Dawn Parker [États-Unis] ; Andrew C. Good [États-Unis] ; Ramkumar Rajamani [États-Unis] ; Fiona Mcphee [États-Unis] ; Nicholas A. Meanwell [États-Unis] ; Paul M. Scola [États-Unis] | P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. |
| 000C59 (2018) |
Luca Sancineto [Pologne] ; Nunzio Iraci [Italie] ; Oriana Tabarrini [Italie] ; Claudio Santi [Italie] | NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors. |
| 000C91 (2018) |
Gaochan Wu [République populaire de Chine] ; Waleed A. Zalloum [Jordanie] ; Megan E. Meuser [États-Unis] ; Lanlan Jing [République populaire de Chine] ; Dongwei Kang [République populaire de Chine] ; Chin-Ho Chen [États-Unis] ; Ye Tian [République populaire de Chine] ; Fangfang Zhang [République populaire de Chine] ; Simon Cocklin [États-Unis] ; Kuo-Hsiung Lee [États-Unis] ; Xinyong Liu [République populaire de Chine] ; Peng Zhan [République populaire de Chine] | Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library. |
| 000C95 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
| 000D02 (2018) |
Jeanne M. Sisk [États-Unis] ; Matthew B. Frieman [États-Unis] ; Carolyn E. Machamer [États-Unis] | Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. |
